134 related articles for article (PubMed ID: 9503162)
21. Development and characterization of a polyclonal antibody against rat liver mitochondrial overt carnitine palmitoyltransferase (CPT I). Distinction of CPT I from CPT II and of isoforms of CPT I in different tissues.
Kolodziej MP; Crilly PJ; Corstorphine CG; Zammit VA
Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):415-21. PubMed ID: 1546954
[TBL] [Abstract][Full Text] [Related]
22. Characterization of hepatic carnitine palmitoyltransferase. Use of bromoacyl derivatives and antibodies.
Brady PS; Dunker AK; Brady LJ
Biochem J; 1987 Feb; 241(3):751-7. PubMed ID: 3593221
[TBL] [Abstract][Full Text] [Related]
23. Comparisons of flux control exerted by mitochondrial outer-membrane carnitine palmitoyltransferase over ketogenesis in hepatocytes and mitochondria isolated from suckling or adult rats.
New KJ; Krauss S; Elliott KR; Quant PA
Eur J Biochem; 1999 Feb; 259(3):684-91. PubMed ID: 10092853
[TBL] [Abstract][Full Text] [Related]
24. L-carnitine ameliorates cancer cachexia in mice by regulating the expression and activity of carnitine palmityl transferase.
Liu S; Wu HJ; Zhang ZQ; Chen Q; Liu B; Wu JP; Zhu L
Cancer Biol Ther; 2011 Jul; 12(2):125-30. PubMed ID: 21532335
[TBL] [Abstract][Full Text] [Related]
25. Feeding of lovastatin to rats increases the activity of the hepatic mitochondrial outer carnitine palmitoyltransferase.
Cook GA; Khan B; Heimberg M
Biochem Biophys Res Commun; 1988 Feb; 150(3):1077-82. PubMed ID: 3342059
[TBL] [Abstract][Full Text] [Related]
26. Aspects of long-chain acyl-COA metabolism.
Tol VA
Mol Cell Biochem; 1975 Apr; 7(1):19-31. PubMed ID: 1134497
[TBL] [Abstract][Full Text] [Related]
27. Rat liver mitochondrial contact sites and carnitine palmitoyltransferase-I.
Hoppel C; Kerner J; Turkaly P; Tandler B
Arch Biochem Biophys; 2001 Aug; 392(2):321-5. PubMed ID: 11488608
[TBL] [Abstract][Full Text] [Related]
28. Hepatic and cardiac carnitine palmitoyltransferase activity. Effects of adriamycin and galactosamine.
Brady LJ; Brady PS
Biochem Pharmacol; 1987 Oct; 36(20):3419-23. PubMed ID: 3675604
[TBL] [Abstract][Full Text] [Related]
29. Changes in hepatic lipid metabolism associated with lipid accumulation and its reversal in rats given the peroxisome proliferator LY171883.
Foxworthy PS; Perry DN; Hoover DM; Eacho PI
Toxicol Appl Pharmacol; 1990 Dec; 106(3):375-83. PubMed ID: 1979695
[TBL] [Abstract][Full Text] [Related]
30. Re-evaluation of the interaction of malonyl-CoA with the rat liver mitochondrial carnitine palmitoyltransferase system by using purified outer membranes.
Kolodziej MP; Zammit VA
Biochem J; 1990 Apr; 267(1):85-90. PubMed ID: 2327991
[TBL] [Abstract][Full Text] [Related]
31. A proportion of rat liver mitochondrial carnitine palmitoyltransferase can be made activatable by malonyl-CoA.
Ghadiminejad I; Saggerson D
Biochim Biophys Acta; 1991 Oct; 1085(3):377-80. PubMed ID: 1911872
[TBL] [Abstract][Full Text] [Related]
32. Stereoisomeric acylamidomorpholinium carnitine analogues: selective inhibitors of carnitine palmitoyltransferase I and II.
Savle PS; Pande SV; Lee TS; Gandour RD
Bioorg Med Chem Lett; 1999 Nov; 9(21):3099-102. PubMed ID: 10560732
[TBL] [Abstract][Full Text] [Related]
33. Carnitine palmitoyltransferase II specificity towards beta-oxidation intermediates--evidence for a reverse carnitine cycle in mitochondria.
Ventura FV; Ijlst L; Ruiter J; Ofman R; Costa CG; Jakobs C; Duran M; Tavares de Almeida I; Bieber LL; Wanders RJ
Eur J Biochem; 1998 May; 253(3):614-8. PubMed ID: 9654057
[TBL] [Abstract][Full Text] [Related]
34. Alterations in the regulatory properties of hepatic fatty acid oxidation and carnitine palmitoyltransferase I activity after ethanol feeding and withdrawal.
Guzmán M; Castro J
Alcohol Clin Exp Res; 1990 Jun; 14(3):472-7. PubMed ID: 2378434
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of mitochondrial carnitine palmitoyltransferase-1 by a trimetazidine derivative, S-15176.
Hamdan M; Urien S; Le Louet H; Tillement JP; Morin D
Pharmacol Res; 2001 Aug; 44(2):99-104. PubMed ID: 11516258
[TBL] [Abstract][Full Text] [Related]
36. Time-dependence of inhibition of carnitine palmitoyltransferase I by malonyl-CoA in mitochondria isolated from livers of fed or starved rats. Evidence for transition of the enzyme between states of low and high affinity for malonyl-CoA.
Zammit VA
Biochem J; 1984 Mar; 218(2):379-86. PubMed ID: 6712621
[TBL] [Abstract][Full Text] [Related]
37. L-carnitine ameliorates the liver inflammatory response by regulating carnitine palmitoyltransferase I-dependent PPARγ signaling.
Jiang F; Zhang Z; Zhang Y; Wu J; Yu L; Liu S
Mol Med Rep; 2016 Feb; 13(2):1320-8. PubMed ID: 26647854
[TBL] [Abstract][Full Text] [Related]
38. The effect of dietary lipid manipulation on hepatic mitochondrial phospholipid fatty acid composition and carnitine palmitoyltransferase I activity.
Power GW; Yaqoob P; Harvey DJ; Newsholme EA; Calder PC
Biochem Mol Biol Int; 1994 Oct; 34(4):671-84. PubMed ID: 7866292
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of carnitine palmitoyltransferase of the hepatic mitochondrial outer membrane (CPT-I) by 2-bromopalmitoyl-CoA.
Kashfi K; Cook GA
Biochem Soc Trans; 1993 Nov; 21(4):503S. PubMed ID: 8132070
[No Abstract] [Full Text] [Related]
40. Flux control exerted by mitochondrial outer membrane carnitine palmitoyltransferase over beta-oxidation, ketogenesis and tricarboxylic acid cycle activity in hepatocytes isolated from rats in different metabolic states.
Drynan L; Quant PA; Zammit VA
Biochem J; 1996 Aug; 317 ( Pt 3)(Pt 3):791-5. PubMed ID: 8760364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]